Scientists and the Regulation of Risk: Standardising ControlRisks are increasingly regulated by international standards, and scientists play a key role in standardisation. This fascinating book exposes the action of 'invisible colleges' of scientists - loose groups of prominent scientific experts who combi |
From inside the book
Results 1-5 of 55
Page 6
... adverse health events. To establish an official product specification (e.g. define the dose at which a particular ... drug reactions (ADRs) by law should be signalled, in particular serious and rare ones. Dedicated formats, reporting ...
... adverse health events. To establish an official product specification (e.g. define the dose at which a particular ... drug reactions (ADRs) by law should be signalled, in particular serious and rare ones. Dedicated formats, reporting ...
Page 7
... adverse drug reactions were collected by national, European and worldwide centres of pharma- covigilance such as the World Health Organization (WHO) centre for the monitoring of medicines.12 In food, a company is required to record and ...
... adverse drug reactions were collected by national, European and worldwide centres of pharma- covigilance such as the World Health Organization (WHO) centre for the monitoring of medicines.12 In food, a company is required to record and ...
Page 8
... adverse drug reactions occur, and to mitigate them if all that is known about a drug is recapitulated and centralised in one place before it enters the market; the notion that the prevalence of food contaminations could greatly be ...
... adverse drug reactions occur, and to mitigate them if all that is known about a drug is recapitulated and centralised in one place before it enters the market; the notion that the prevalence of food contaminations could greatly be ...
Page 10
... adverse events and with what effect.17 Stating that scientists standardise control of products means that, beyond their professional role of testing products and substances, assess- ing risks or monitoring adverse drug reactions or food ...
... adverse events and with what effect.17 Stating that scientists standardise control of products means that, beyond their professional role of testing products and substances, assess- ing risks or monitoring adverse drug reactions or food ...
Page 12
... adverse side - effects . They have given rise , alone or in relation to other disciplines , to the practice of drug safety evaluation , of food control and food risk assessment . These sciences are dynamic : from an initial programme of ...
... adverse side - effects . They have given rise , alone or in relation to other disciplines , to the practice of drug safety evaluation , of food control and food risk assessment . These sciences are dynamic : from an initial programme of ...
Contents
1 | |
19 | |
a short history of risk regulation | 37 |
medical professionals and the introduction of pharmacovigilance planning | 77 |
HACCP and the ambitions of the food microbiology elite | 112 |
food safety scientists and the invention of postmarket monitoring | 142 |
sociology of the standardising scientist | 167 |
the emergent action of invisible colleges | 191 |
Research strategy and methodology | 211 |
References | 216 |
Index | 255 |
Other editions - View all
Scientists and the Regulation of Risk: Standardising Control David Demortain No preview available - 2011 |
Common terms and phrases
academic activities actors adoption adverse drug reactions adverse events application cerivastatin chemical CIOMS circulation clinical pharmacology clinical trials companies consumer criteria critical control points decision defined diseases domain drug safety experts effects EMEA emerged epistemic communities European Commission evaluation expertise food additives food businesses food contaminations Food Control food hygiene food microbiologists food production food regulation food safety functional foods global governments guideline HACCP harmonisation hazard ICMSF ILSI industry intervention invisible college involved knowledge marketing authorisation methodologies microbiological monitoring mycoprotein networks novel foods organisations particular patients pharma Pharmacoepidemiology pharmacovigilance pharmacovigilance planning phytosterol political post-marketing practice principles professional regimes regulatory agencies regulatory concepts responsibility risk analysis risk assessment risk management risk regulation role safety issues scientific advisers scientific experts scientists social specialists specific standardisation substances testing thalidomide tion tool toxicology transnational Unilever